Traws Pharma Inc.

NASDAQ: TRAW · Real-Time Price · USD
1.48
-0.14 (-8.64%)
At close: Aug 15, 2025, 12:39 PM

Traws Pharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.73M 57K 56K 57K 57K 56K 56K 57K 57K 56K 56K 57K 57K 56K 56K 57K 57K 56K
Cost of Revenue
n/a 1K 2K 2K 4K 4K 4K 5K 4K 3K 4K 3K 4K 3K 4K n/a n/a n/a
Gross Profit
2.73M 56K 54K 55K 53K 52K 52K 52K 53K 53K 52K 54K 53K 53K 52K n/a n/a n/a
Operating Income
-1.25M -5.2M -29.72M -8.54M -5.88M -5.21M -4.46M -5.09M -4.61M -6.14M -5.73M -5.64M -4.12M -4.13M -3.76M -3.99M -4.64M -4.1M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-915K 21.49M -29.92M -8.47M -123.14M -4.98M -4.18M -4.74M -4.25M -5.78M -5.42M -5.4M -4.02M -4.12M -3.76M -3.45M -4.23M -4.71M
Net Income
-915K 15.08M 81.93M -8.47M -123.14M -4.98M -4.18M -4.74M -4.25M -5.78M -5.42M -5.4M -4.02M -4.12M -3.76M -3.45M -4.23M -4.71M
Selling & General & Admin
1.69M 2.75M 3.48M 3.48M 1.98M 3.36M 2.08M 2.68M 2.21M 2.11M 2.02M 2.1M 2.14M 2.19M 2.07M 2.28M 2.85M 2.22M
Research & Development
2.29M 2.5M 1.86M 5.11M 3.96M 1.91M 2.43M 2.46M 2.45M 4.08M 3.77M 3.59M 2.03M 2M 1.74M 1.76M 1.85M 1.93M
Other Expenses
n/a n/a -24.44M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
3.98M 5.26M 29.77M 8.59M 5.94M 5.26M 4.51M 5.14M 4.66M 6.19M 5.79M 5.7M 4.17M 4.18M 3.81M 4.04M 4.7M 4.15M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.98M 5.26M 29.77M 8.59M 5.94M 5.27M 4.52M 5.15M 4.67M 6.19M 5.79M 5.7M 4.18M 4.19M 3.82M 4.05M 4.7M 4.15M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
5.82M 6.97M 3.65M 961.53K 1.01M 841.74K 840.14K 840.12K 839.19K 838.41K 837.04K 836.62K 836.16K 836.16K 835.82K 639.17K 631.23K 584.64K
Shares Outstanding (Diluted)
5.82M 7.22M 3.65M 961.53K 1.01M 841.74K 840.14K 840.12K 839.19K 838.41K 837.04K 836.62K 836.16K 836.16K 835.82K 639.17K 631.23K 584.64K
EPS (Basic)
-0.11 2.17 22.44 -8.81 -121.63 -5.92 -4.98 -5.64 -5.06 -6.89 -6.48 -6.45 -4.81 -4.93 -4.5 -5.4 -6.7 -8.07
EPS (Diluted)
-0.11 2.09 22.44 -8.81 -121.63 -5.92 -4.98 -5.64 -5.06 -6.89 -6.48 -6.45 -4.81 -4.93 -4.5 -5.4 -6.7 -8.07
EBITDA
-914K 21.49M -29.92M -8.47M -123.14M -4.98M -4.18M -4.73M -4.25M -5.77M -5.42M -5.39M -4.02M -4.12M -3.76M -3.45M -4.23M -4.71M
EBIT
-915K 21.49M -29.92M -8.47M -123.14M -4.98M -4.18M -4.74M -4.25M -5.78M -5.42M -5.4M -4.02M -4.12M -3.76M -3.45M -4.23M -4.71M
Depreciation & Amortization
1K 1K 2K 2K 4K 4K 4K 5K 4K 3K 4K 3K 4K 3K 4K 3K 4K 3K